A case of chronic paclitaxel administration in ovarian cancer
Title
A case of chronic paclitaxel administration in ovarian cancer
Creator
Von Gruenigen V E; Karlen J R; Waggoner S E
Publisher
Gynecologic Oncology
Date
2003
2003-06
Description
Background. Treatment with chemotherapeutic agents, after initial ovarian tumor debulking, and during recurrence, results in extended chemotherapy. When ovarian cancer recurs, chemotherapy is continued when patients respond to therapy. However, the disease may become stable. Stable disease is clinically relevant and no longer an indication of treatment failure. Case. A woman with advanced ovarian cancer was treated with cytoxan and cisplatin chemotherapy after having surgical cytoreduction. She progressed and was placed on monthly intravenous paclitaxel. After an initial partial response to therapy, she then went into a prolonged stable course of her disease. She subsequently received 67 cycles of monthly paclitaxel therapy. Conclusion. Chronic administration of paclitaxel resulted in prolonged stabilization of disease and was well tolerated. (C) 2003 Elsevier Science (USA). All rights reserved.
Subject
carcinoma; chronic therapy; cisplatin; cycles; cyclophosphamide; follow-up; free survival; gynecologic malignancies; Obstetrics & Gynecology; Oncology; ovarian-cancer; paclitaxel; phase-ii trial; platinum-based chemotherapy; single-agent paclitaxel
Identifier
Format
Journal Article
URL Address
Search for Full-text
Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
532-535
Issue
3
Volume
89
Citation
Von Gruenigen V E; Karlen J R; Waggoner S E, “A case of chronic paclitaxel administration in ovarian cancer,” NEOMED Bibliography Database, accessed March 30, 2023, https://neomed.omeka.net/items/show/7417.